Delivery Order SPE2DB20D3101-SPE2DB23FRDX6
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company AmerisourceBergen Corporation. The $22,303.54 firm fixed price delivery order is for the provision of 100 mg vials of the pharmaceutical product Remicade. The award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary vehicle for AmerisourceBergen Drug Corp to deliver pharmaceutical...
- This federal contract award, valued at $12,745.09, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is for the delivery of Remicade 100 mg vials, a pharmaceutical product, with a completion date of April 18, 2024. This is a delivery order contract with a firm fixed price pricing type. The award is not associated with any set-aside...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,426.82, is for the delivery of Remicade 100 mg vials, a specialty medication. The contract has an ultimate completion date of November 13, 2024 and is structured as a Firm Fixed Price Delivery Order. This contract award is part of a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,973.67 firm fixed-price delivery order is for the supply of REMICADE 100 MG VIALS, a specialty medication. The contract has an ultimate completion date of November 5, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,877.18 firm fixed-price delivery order is for the supply of 100 mg vials of the drug Remicade, with a completion date of January 31, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Remicade 100 mg vials. The contract, valued at $14,718, is a delivery order with a firm fixed price and an ultimate completion date of August 8, 2023. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $24,148.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is a delivery order (Contract #SPE2DB22D2206) under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 and running through November 2026. The contract is for the delivery of Remicade 100 mg vials, a specialty pharmaceutical product. This award does not have a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $41,679.13, is for the delivery of Remicade 100 mg vials to support federal healthcare programs. The contract is a Firm Fixed Price Delivery Order, with a completion date of January 3, 2024. It is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $7,279.02 Firm Fixed Price Delivery Order contract is for the supply of REMICADE 100 MG VIALS, a prescription medication, with a completion date of April 18, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a single-award Indefinite...
- This federal contract award, valued at $13,288.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has no set-aside designation, is a Delivery Order for Remicade 100 mg vials. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FRDX6Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,064.64 firm-fixed-price delivery order is for 100 mg vials of the medication Remicade. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical division. The IDC, which runs through November 2026, enables the efficient procurement of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award did not have a set-aside designation, indicating open competition. AmerisourceBergen's parent company is Cencora, Inc., which also holds a smaller $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 3/1/23 |